Whalegun
Home

James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Planned sale · Filed 09/22

Trade details

Type
Planned sale notice
Stock
Crispr Therapeutics CRSP
Person
James R. KasingerGeneral Counsel and Secretary
Planned sale date
26/09/22
Filed
26/09/22

$626.5K to be sold

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 08/23~10/22

James R. Kasinger's recent trades

  • James R. Kasinger

    Sell10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/24

  • James R. Kasinger

    SellCrispr Therapeutics

    $148.9K

    Filed 03/24

  • James R. Kasinger

    SellCrispr Therapeutics

    $166.5K

    Filed 03/17

  • James R. Kasinger

    SellCrispr Therapeutics

    $147.8K

    Filed 03/12

  • James R. Kasinger

    SellCrispr Therapeutics

    $111K

    Filed 02/20

James R. Kasinger, General Counsel — plans to sell 10,400 sh of Crispr Therapeutics CRSP · $626.5K · around 09/22 · 10b5-1 plan | Whalegun